Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.
Khamashta
M A
MA
Lupus Unit, King's College London School of Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Hunt
B J
BJ
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D016736:Antiphospholipid Syndrome / Q000188:drug therapy*; D001241:Aspirin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D006470:Hemorrhage; D006801:Humans; D019934:International Normalized Ratio; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008297:Male; D011247:Pregnancy; D012008:Recurrence; D012189:Retrospective Studies; D012306:Risk; D014812:Vitamin K / Q000037:antagonists & inhibitors; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use
D000925:Anticoagulants; D014812:Vitamin K; D014859:Warfarin; D001241:Aspirin